Arrowhead Pharmaceuticals
ARWR
$22.12
Share price
1.14%
Change (1 day)
-37.73%
Change (1 year)
Categories
EPS for Arrowhead Pharmaceuticals (ARWR)
EPS in 2023 (TTM): -$1.70
According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.70. In 2022 the company made an earnings per share (EPS) of -$1.46 an increase over its 2021 EPS that were of -$1.76.
EPS history for Arrowhead Pharmaceuticals from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$1.70 | 16.44% |
| 2022 | -$1.46 | -17.05% |
| 2021 | -$1.76 | 74.26% |
| 2020 | -$1.01 | -283.64% |
| 2019 | $0.55 | -257.14% |
| 2018 | -$0.35 | -27.08% |
| 2017 | -$0.48 | -59.32% |
| 2016 | -$1.18 | -21.85% |
| 2015 | -$1.51 | 9.42% |
| 2014 | -$1.38 | 2.87% |
| 2013 | -$1.34 | -31.56% |
| 2012 | -$1.96 | 300% |
| 2011 | -$0.49 | -45.56% |
| 2010 | -$0.90 | -66.67% |
| 2009 | -$2.70 | -63.51% |
| 2008 | -$7.40 | -12.94% |
| 2007 | -$8.50 | 44.07% |
| 2006 | -$5.90 | 77.35% |
| 2005 | -$3.33 | 10.66% |
| 2004 | -$3.01 | -54.25% |
| 2003 | -$6.57 | -80.51% |
| 2002 | -$33.72 | 3.87% |
| 2001 | -$32.46 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -928.55% | 🇺🇸 USA |
 Moderna
MRNA | -$9.14 | 437.65% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $1.57 | -192.35% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$4.11 | 141.76% | 🇺🇸 USA |
 Inovio Pharmaceuticals INO | -$0.65 | -61.76% | 🇺🇸 USA |